The expression of hormone receptors was significantly higher in HER2-low compared with the HER2 0 tumours (p < 0.001) [26] but there was no significant difference in disease-free or overall survival between hormone receptor positive and hormone receptor negative HER-2 low tumours. This evidence concerns the gene ERBB2 and neoplasm.